US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.53

+0.170012.50%

Pre-market: 1.530.00000.00%08:00 EDT

Volume:922.30K

Turnover:1.41M

Market Cap:92.68M

PE:-0.68

High:1.60

Open:1.36

Low:1.36

Close:1.36

52wk High:3.36

52wk Low:0.8551

Shares:60.57M

Float Shares:32.93M

Volume Ratio:7.27

T/O Rate:2.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2658

EPS(LYR):-1.7051

ROE:-75.71%

ROA:-39.06%

PB:0.79

PE(LYR):-0.90

Loading ...

Overview Company News Filings

Acumen price target lowered to $9 from $10 at BofA

BTIG Keeps Their Buy Rating on Acumen Pharmaceuticals (ABOS)

Citi Sticks to Their Buy Rating for Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -41.75 Million

Acumen Pharmaceuticals Q2 EPS $(0.68) Misses $(0.52) Estimate

Acumen Pharmaceuticals Inc - Topline Results for Altitude-Ad Phase 2 Expected Late 2026

THOMSON REUTERS

Acumen Pharmaceuticals, Inc. Q2 Operating Expenses USD 41.75 Million

THOMSON REUTERS

Acumen Pharmaceuticals, Inc. Q2 Net Income USD -40.95 Million

THOMSON REUTERS

Acumen Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview

Acumen Pharmaceuticals Inc. to Report Second Quarter 2025 Financial Results

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Acumen Pharmaceuticals’ Promising Alzheimer’s Study: A Potential Game-Changer?

Acumen Pharmaceuticals Announces 40% Cost Reduction in Phase 2 Alzheimer's Trial with Innovative pTau217 Screening Assay

Acumen Pharmaceuticals Presents Studies Showing the Utility of a Ptau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (Aaic) 2025

THOMSON REUTERS

Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Treatment

Acumen, JCR enter agreement to develop therapeutic candidate for Alzheimer’s

Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease

Acumen Pharmaceuticals Unveils New Cost-Saving Screening Assay in Phase 2 Alzheimer's Study at 2025 AAIC Conference

Acumen Pharmaceuticals Initiated at Buy by Citigroup

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ABOS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","market":"US","secType":"STK","nameCN":"Acumen Pharmaceuticals, Inc.","latestPrice":1.53,"timestamp":1755892800000,"preClose":1.36,"halted":0,"volume":922301,"hourTrading":{"tag":"盘前","latestPrice":1.53,"preClose":1.53,"latestTime":"08:00 EDT","volume":106,"amount":162.18,"timestamp":1756123201341},"delay":0,"floatShares":32929494,"shares":60573425,"eps":-2.265848,"marketStatus":"Pre-Mkt","change":0.17,"latestTime":"08-25 08:22:18 EDT","open":1.36,"high":1.6,"low":1.36,"amount":1405757.1652248001,"amplitude":0.176471,"askPrice":1.68,"askSize":200,"bidPrice":1.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.265848,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756128600000},"marketStatusCode":1,"adr":0,"listingDate":1625112000000,"exchange":"NASDAQ","adjPreClose":1.53,"preHourTrading":{"tag":"盘前","latestPrice":1.53,"preClose":1.53,"latestTime":"08:00 EDT","volume":106,"amount":162.18,"timestamp":1756123201341},"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.53,"latestTime":"19:55 EDT","volume":2912,"amount":4447.6851,"timestamp":1755906938621},"volumeRatio":7.270433329486077,"impliedVol":0.145,"impliedVolPercentile":0.012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","floatShares":32929494,"roa":"-39.06%","roe":"-75.71%","lyrEps":-1.705106,"volumeRatio":7.270433329486077,"shares":60573425,"dividePrice":0,"high":1.6,"amplitude":0.176471,"preClose":1.36,"low":1.36,"week52Low":0.8551,"pbRate":"0.79","week52High":3.36,"institutionHeld":0,"latestPrice":1.53,"committee":-0.333333,"eps":-2.265848,"divideRate":0,"volume":922301,"delay":0,"ttmEps":-2.265848,"open":1.36,"prevYearClose":1.72,"prevWeekClose":1.53,"prevMonthClose":1.4,"prevQuarterClose":1.16,"fiveDayClose":1.42,"twentyDayClose":1.57,"sixtyDayClose":1.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"ABOS","fiscalQuarterEnding":"2025/06","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-05-13","symbol":"ABOS","fiscalQuarterEnding":"2025/03","expectedEps":-0.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2025-03-27","symbol":"ABOS","fiscalQuarterEnding":"2024/12","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2024-11-12","symbol":"ABOS","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-13","symbol":"ABOS","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1750219200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABOS","date":"2025-08-22","current":-0.602787,"percent":0.965312,"low":-24.285355,"twenty":-6.348535,"median":-3.530944,"eighty":-1.613202,"high":-0.510632,"avg":-4.376742,"sd":3.833764,"marketCap":82379858},"quantilePoints":[{"date":"2021-07-02","current":-24.285355,"twenty":-23.282602,"median":-17.962584,"eighty":-17.962584,"marketCap":783858402},{"date":"2021-07-09","current":-22.632801,"twenty":-23.49497,"median":-22.453176,"eighty":-17.962584,"marketCap":730518925},{"date":"2021-07-16","current":-21.387398,"twenty":-22.821186,"median":-22.058,"eighty":-19.615112,"marketCap":690321058},{"date":"2021-07-23","current":-20.453346,"twenty":-22.762131,"median":-21.9622,"eighty":-20.489271,"marketCap":660172658},{"date":"2021-07-30","current":-18.537342,"twenty":-22.651961,"median":-21.004198,"eighty":-18.192479,"marketCap":598329786},{"date":"2021-08-06","current":-17.974516,"twenty":-22.525026,"median":-20.513221,"eighty":-17.962584,"marketCap":580163442},{"date":"2021-08-13","current":-18.166116,"twenty":-22.280735,"median":-19.189981,"eighty":-17.931406,"marketCap":586347730},{"date":"2021-08-20","current":-7.634154,"twenty":-22.15859,"median":-18.285866,"eighty":-17.71346,"marketCap":699288543},{"date":"2021-08-27","current":-8.252662,"twenty":-22.03884,"median":-17.992479,"eighty":-8.058274,"marketCap":755943865},{"date":"2021-09-03","current":-6.887527,"twenty":-21.617319,"median":-17.962584,"eighty":-7.680984,"marketCap":630897476},{"date":"2021-09-10","current":-7.510453,"twenty":-21.349078,"median":-17.950566,"eighty":-7.666847,"marketCap":687957479},{"date":"2021-09-17","current":-7.170273,"twenty":-21.061678,"median":-17.84279,"eighty":-7.521056,"marketCap":656797052},{"date":"2021-09-24","current":-7.130512,"twenty":-20.654527,"median":-17.663165,"eighty":-7.137581,"marketCap":653154924},{"date":"2021-10-01","current":-6.746154,"twenty":-20.541962,"median":-12.845778,"eighty":-7.060709,"marketCap":617947688},{"date":"2021-10-08","current":-5.942094,"twenty":-20.489271,"median":-8.093617,"eighty":-6.829211,"marketCap":544295770},{"date":"2021-10-15","current":-5.986273,"twenty":-20.209056,"median":-7.868304,"eighty":-6.749688,"marketCap":548342578},{"date":"2021-10-22","current":-6.35296,"twenty":-19.320509,"median":-7.709259,"eighty":-6.596828,"marketCap":581931091},{"date":"2021-10-29","current":-6.207168,"twenty":-18.460702,"median":-7.618691,"eighty":-6.547348,"marketCap":568576622},{"date":"2021-11-05","current":-6.573855,"twenty":-18.321792,"median":-7.510453,"eighty":-6.499634,"marketCap":602165134},{"date":"2021-11-12","current":-5.721198,"twenty":-18.237966,"median":-7.159228,"eighty":-6.436016,"marketCap":524061726},{"date":"2021-11-19","current":-4.290171,"twenty":-18.103846,"median":-7.121676,"eighty":-6.359144,"marketCap":399037384},{"date":"2021-11-26","current":-3.598348,"twenty":-18.003256,"median":-7.081915,"eighty":-6.245163,"marketCap":334689571},{"date":"2021-12-03","current":-3.398198,"twenty":-17.97213,"median":-6.960422,"eighty":-6.12853,"marketCap":316073222},{"date":"2021-12-10","current":-3.063165,"twenty":-17.962584,"median":-6.808005,"eighty":-5.947395,"marketCap":284911073},{"date":"2021-12-17","current":-2.993547,"twenty":-17.962584,"median":-6.759408,"eighty":-5.733568,"marketCap":278435822},{"date":"2021-12-23","current":-3.076218,"twenty":-17.962584,"median":-6.746154,"eighty":-4.668715,"marketCap":286125183},{"date":"2021-12-31","current":-2.941334,"twenty":-17.950566,"median":-6.693139,"eighty":-3.915978,"marketCap":273579383},{"date":"2022-01-07","current":-2.501875,"twenty":-17.902666,"median":-6.569437,"eighty":-3.533082,"marketCap":232704357},{"date":"2022-01-14","current":-2.340884,"twenty":-17.84279,"median":-6.560601,"eighty":-3.298123,"marketCap":217730337},{"date":"2022-01-21","current":-2.253863,"twenty":-17.84279,"median":-6.529676,"eighty":-3.128431,"marketCap":209636273},{"date":"2022-01-28","current":-2.179894,"twenty":-17.76615,"median":-6.50096,"eighty":-3.056203,"marketCap":202756318},{"date":"2022-02-04","current":-2.166841,"twenty":-17.67993,"median":-6.441318,"eighty":-3.000509,"marketCap":201542208},{"date":"2022-02-11","current":-2.345235,"twenty":-17.567365,"median":-6.368422,"eighty":-2.938723,"marketCap":218135040},{"date":"2022-02-18","current":-2.571492,"twenty":-17.399714,"median":-6.357377,"eighty":-2.830816,"marketCap":239179608},{"date":"2022-02-25","current":-2.488821,"twenty":-11.942176,"median":-6.255765,"eighty":-2.557568,"marketCap":231490247},{"date":"2022-03-04","current":-2.184245,"twenty":-8.282704,"median":-6.180661,"eighty":-2.531462,"marketCap":203161021},{"date":"2022-03-11","current":-2.397448,"twenty":-8.157235,"median":-6.127646,"eighty":-2.498394,"marketCap":222991479},{"date":"2022-03-18","current":-2.789046,"twenty":-8.090966,"median":-5.966392,"eighty":-2.491432,"marketCap":259414770},{"date":"2022-03-25","current":-2.236458,"twenty":-7.98582,"median":-5.942094,"eighty":-2.48534,"marketCap":208017460},{"date":"2022-04-01","current":-1.613202,"twenty":-7.858585,"median":-5.752123,"eighty":-2.459234,"marketCap":162297812},{"date":"2022-04-08","current":-1.609179,"twenty":-7.787898,"median":-4.68612,"eighty":-2.395708,"marketCap":161893080},{"date":"2022-04-14","current":-1.59711,"twenty":-7.743719,"median":-4.477268,"eighty":-2.375693,"marketCap":160678881},{"date":"2022-04-22","current":-1.653432,"twenty":-7.680984,"median":-4.068266,"eighty":-2.340884,"marketCap":166345139},{"date":"2022-04-29","current":-1.55375,"twenty":-7.636805,"median":-3.598348,"eighty":-2.293893,"marketCap":156316536},{"date":"2022-05-06","current":-1.465194,"twenty":-7.621784,"median":-3.48522,"eighty":-2.261695,"marketCap":147407303},{"date":"2022-05-13","current":-1.340411,"twenty":-7.576721,"median":-3.311177,"eighty":-2.229496,"marketCap":134853384},{"date":"2022-05-20","current":-1.703502,"twenty":-7.526357,"median":-3.263314,"eighty":-2.181634,"marketCap":140944377},{"date":"2022-05-27","current":-1.742663,"twenty":-7.455671,"median":-3.076218,"eighty":-2.166841,"marketCap":144184478},{"date":"2022-06-03","current":-1.801405,"twenty":-7.332853,"median":-3.063165,"eighty":-1.916589,"marketCap":149044629},{"date":"2022-06-10","current":-1.879727,"twenty":-7.165855,"median":-3.024005,"eighty":-1.875701,"marketCap":155524830},{"date":"2022-06-17","current":-1.61539,"twenty":-7.14465,"median":-3.002249,"eighty":-1.786719,"marketCap":133654151},{"date":"2022-06-24","current":-1.835671,"twenty":-7.130512,"median":-2.971792,"eighty":-1.762051,"marketCap":151879717},{"date":"2022-07-01","current":-2.305602,"twenty":-7.121676,"median":-2.934807,"eighty":-1.786719,"marketCap":190760925},{"date":"2022-07-08","current":-2.932178,"twenty":-7.093402,"median":-2.93023,"eighty":-1.786719,"marketCap":242602535},{"date":"2022-07-15","current":-3.079032,"twenty":-7.082799,"median":-2.928281,"eighty":-1.798468,"marketCap":254752912},{"date":"2022-07-22","current":-3.074136,"twenty":-7.053641,"median":-2.93023,"eighty":-1.805321,"marketCap":254347900},{"date":"2022-07-29","current":-2.662946,"twenty":-7.035969,"median":-2.893472,"eighty":-1.8063,"marketCap":220326843},{"date":"2022-08-05","current":-2.555254,"twenty":-6.916685,"median":-2.888122,"eighty":-1.829797,"marketCap":211416566},{"date":"2022-08-12","current":-2.643366,"twenty":-6.866321,"median":-2.848961,"eighty":-1.866889,"marketCap":218706793},{"date":"2022-08-19","current":-6.140146,"twenty":-6.966193,"median":-2.888122,"eighty":-1.87872,"marketCap":193604932},{"date":"2022-08-26","current":-7.052176,"twenty":-7.035969,"median":-2.893472,"eighty":-1.891475,"marketCap":222362150},{"date":"2022-09-02","current":-7.411849,"twenty":-7.058124,"median":-2.93023,"eighty":-1.921825,"marketCap":233703025},{"date":"2022-09-09","current":-8.657862,"twenty":-7.09585,"median":-2.939203,"eighty":-1.943364,"marketCap":272991055},{"date":"2022-09-16","current":-7.052176,"twenty":-7.137581,"median":-2.966444,"eighty":-1.985462,"marketCap":222362150},{"date":"2022-09-23","current":-5.947463,"twenty":-7.12521,"median":-2.997898,"eighty":-2.053302,"marketCap":187529464},{"date":"2022-09-30","current":-12.884029,"twenty":-7.15702,"median":-3.015395,"eighty":-2.099834,"marketCap":406246333},{"date":"2022-10-07","current":-12.614274,"twenty":-7.388838,"median":-3.045761,"eighty":-2.133486,"marketCap":397740677},{"date":"2022-10-14","current":-10.160785,"twenty":-7.596303,"median":-3.064346,"eighty":-2.159688,"marketCap":320379710},{"date":"2022-10-21","current":-9.813957,"twenty":-7.732232,"median":-3.076218,"eighty":-2.166841,"marketCap":309443867},{"date":"2022-10-28","current":-9.197373,"twenty":-7.820986,"median":-3.141484,"eighty":-2.166841,"marketCap":290002367},{"date":"2022-11-04","current":-8.169734,"twenty":-8.037325,"median":-3.289421,"eighty":-2.169452,"marketCap":257599868},{"date":"2022-11-11","current":-8.734935,"twenty":-8.202905,"median":-3.398198,"eighty":-2.176413,"marketCap":275421243},{"date":"2022-11-18","current":-6.490146,"twenty":-8.124064,"median":-3.535258,"eighty":-2.182505,"marketCap":248825726},{"date":"2022-11-25","current":-6.607567,"twenty":-8.09185,"median":-3.757163,"eighty":-2.187726,"marketCap":253327507},{"date":"2022-12-02","current":-5.977767,"twenty":-8.054616,"median":-4.220554,"eighty":-2.201649,"marketCap":229181590},{"date":"2022-12-09","current":-6.532845,"twenty":-7.992466,"median":-4.572991,"eighty":-2.219924,"marketCap":250462738},{"date":"2022-12-16","current":-6.105861,"twenty":-7.961637,"median":-5.156037,"eighty":-2.229496,"marketCap":234092624},{"date":"2022-12-23","current":-5.561458,"twenty":-7.929869,"median":-5.598819,"eighty":-2.233847,"marketCap":213220729},{"date":"2022-12-30","current":-5.764275,"twenty":-7.898102,"median":-5.598819,"eighty":-2.239939,"marketCap":220996533},{"date":"2023-01-06","current":-5.593482,"twenty":-7.822905,"median":-5.620168,"eighty":-2.253863,"marketCap":214448488},{"date":"2023-01-13","current":-6.66094,"twenty":-7.819707,"median":-5.703399,"eighty":-2.258214,"marketCap":255373772},{"date":"2023-01-20","current":-6.105861,"twenty":-7.811989,"median":-5.732251,"eighty":-2.265176,"marketCap":234092624},{"date":"2023-01-27","current":-5.817648,"twenty":-7.77923,"median":-5.773662,"eighty":-2.270397,"marketCap":223042797},{"date":"2023-02-03","current":-6.137885,"twenty":-7.767658,"median":-5.817648,"eighty":-2.274748,"marketCap":235320383},{"date":"2023-02-10","current":-6.084512,"twenty":-7.720746,"median":-5.860346,"eighty":-2.28606,"marketCap":233274118},{"date":"2023-02-17","current":-5.881695,"twenty":-7.652709,"median":-5.881695,"eighty":-2.2983,"marketCap":225498314},{"date":"2023-02-24","current":-5.593482,"twenty":-7.635921,"median":-5.838997,"eighty":-2.301318,"marketCap":214448488},{"date":"2023-03-03","current":-5.582807,"twenty":-7.615599,"median":-5.817648,"eighty":-2.301725,"marketCap":214039235},{"date":"2023-03-10","current":-4.86761,"twenty":-7.596303,"median":-5.817648,"eighty":-2.304051,"marketCap":186619295},{"date":"2023-03-17","current":-4.131064,"twenty":-7.55885,"median":-5.764275,"eighty":-2.311108,"marketCap":158380849},{"date":"2023-03-24","current":-4.184437,"twenty":-7.521056,"median":-5.732251,"eighty":-2.321021,"marketCap":160427113},{"date":"2023-03-31","current":-3.886544,"twenty":-7.451291,"median":-5.696476,"eighty":-2.334604,"marketCap":166561751},{"date":"2023-04-06","current":-3.656798,"twenty":-7.396509,"median":-5.678878,"eighty":-2.340884,"marketCap":156715736},{"date":"2023-04-14","current":-3.714235,"twenty":-7.347733,"median":-5.63618,"eighty":-2.342624,"marketCap":159177240},{"date":"2023-04-21","current":-3.829108,"twenty":-7.288533,"median":-5.625505,"eighty":-2.346976,"marketCap":164100248},{"date":"2023-04-28","current":-3.656798,"twenty":-7.222732,"median":-5.593482,"eighty":-2.360029,"marketCap":156715736},{"date":"2023-05-05","current":-3.876972,"twenty":-7.161437,"median":-5.593482,"eighty":-2.375693,"marketCap":166151501},{"date":"2023-05-12","current":-5.219914,"twenty":-7.141115,"median":-5.582807,"eighty":-2.377433,"marketCap":235073605},{"date":"2023-05-19","current":-5.092377,"twenty":-7.126978,"median":-5.566795,"eighty":-2.383554,"marketCap":229330096},{"date":"2023-05-26","current":-4.418252,"twenty":-7.114429,"median":-5.429439,"eighty":-2.39053,"marketCap":198971550},{"date":"2023-06-02","current":-4.554899,"twenty":-7.102566,"median":-5.219914,"eighty":-2.393967,"marketCap":205125310},{"date":"2023-06-09","current":-4.436471,"twenty":-7.097021,"median":-5.145256,"eighty":-2.397448,"marketCap":199792051},{"date":"2023-06-16","current":-5.110596,"twenty":-7.089836,"median":-5.134474,"eighty":-2.40528,"marketCap":230150597},{"date":"2023-06-23","current":-5.147036,"twenty":-7.086333,"median":-5.156037,"eighty":-2.436608,"marketCap":231791600},{"date":"2023-06-30","current":-4.381813,"twenty":-7.082799,"median":-5.134474,"eighty":-2.437538,"marketCap":197330548},{"date":"2023-07-07","current":-4.600448,"twenty":-7.064072,"median":-5.110596,"eighty":-2.437771,"marketCap":207176563},{"date":"2023-07-14","current":-5.575196,"twenty":-7.052176,"median":-5.110596,"eighty":-2.441687,"marketCap":251073379},{"date":"2023-07-21","current":-9.382079,"twenty":-7.085449,"median":-5.147036,"eighty":-2.448851,"marketCap":422512554},{"date":"2023-07-28","current":-9.253733,"twenty":-7.118052,"median":-5.210804,"eighty":-2.455753,"marketCap":416732628},{"date":"2023-08-04","current":-9.11897,"twenty":-7.240218,"median":-5.320122,"eighty":-2.463585,"marketCap":410663706},{"date":"2023-08-11","current":-8.752,"twenty":-7.404179,"median":-5.397952,"eighty":-2.467066,"marketCap":406906755},{"date":"2023-08-18","current":-7.965898,"twenty":-7.60092,"median":-5.429439,"eighty":-2.46806,"marketCap":370358476},{"date":"2023-08-25","current":-7.61739,"twenty":-7.695122,"median":-5.513668,"eighty":-2.473653,"marketCap":354155293},{"date":"2023-09-01","current":-7.492922,"twenty":-7.770568,"median":-5.575196,"eighty":-2.481859,"marketCap":348368442},{"date":"2023-09-07","current":-7.380902,"twenty":-7.767705,"median":-5.588145,"eighty":-2.487081,"marketCap":343160276},{"date":"2023-09-15","current":-6.85814,"twenty":-7.766715,"median":-5.593482,"eighty":-2.488821,"marketCap":318855501},{"date":"2023-09-22","current":-5.887296,"twenty":-7.732232,"median":-5.602525,"eighty":-2.490499,"marketCap":273718061},{"date":"2023-09-29","current":-5.19028,"twenty":-7.666847,"median":-5.593482,"eighty":-2.49255,"marketCap":241311695},{"date":"2023-10-06","current":-5.576128,"twenty":-7.637688,"median":-5.593482,"eighty":-2.494913,"marketCap":259250933},{"date":"2023-10-12","current":-5.177833,"twenty":-7.635038,"median":-5.579467,"eighty":-2.500134,"marketCap":240733009},{"date":"2023-10-20","current":-4.343904,"twenty":-7.620743,"median":-5.572132,"eighty":-2.501875,"marketCap":201961106},{"date":"2023-10-27","current":-4.007842,"twenty":-7.614901,"median":-5.561458,"eighty":-2.506226,"marketCap":186336608},{"date":"2023-11-03","current":-2.439556,"twenty":-7.6046,"median":-5.465632,"eighty":-2.494913,"marketCap":113422283},{"date":"2023-11-10","current":-2.315089,"twenty":-7.60092,"median":-5.420329,"eighty":-2.494913,"marketCap":107635432},{"date":"2023-11-17","current":-2.659529,"twenty":-7.580741,"median":-5.37478,"eighty":-2.491928,"marketCap":129625466},{"date":"2023-11-24","current":-2.815917,"twenty":-7.53696,"median":-5.352087,"eighty":-2.493172,"marketCap":137247792},{"date":"2023-12-01","current":-2.851561,"twenty":-7.510453,"median":-5.277407,"eighty":-2.501875,"marketCap":138985106},{"date":"2023-12-08","current":-3.338703,"twenty":-7.499934,"median":-5.233843,"eighty":-2.501875,"marketCap":162728395},{"date":"2023-12-15","current":-3.564452,"twenty":-7.477986,"median":-5.219914,"eighty":-2.514928,"marketCap":173731383},{"date":"2023-12-22","current":-3.754556,"twenty":-7.434321,"median":-5.195987,"eighty":-2.526809,"marketCap":182997056},{"date":"2023-12-29","current":-4.550617,"twenty":-7.40566,"median":-5.177833,"eighty":-2.530479,"marketCap":221797065},{"date":"2024-01-05","current":-4.776365,"twenty":-7.387091,"median":-5.160712,"eighty":-2.535132,"marketCap":232800053},{"date":"2024-01-12","current":-4.598143,"twenty":-7.374979,"median":-5.147036,"eighty":-2.538641,"marketCap":224113484},{"date":"2024-01-19","current":-4.372394,"twenty":-7.334851,"median":-5.132811,"eighty":-2.542883,"marketCap":213110496},{"date":"2024-01-26","current":-3.861489,"twenty":-7.296337,"median":-5.106041,"eighty":-2.547996,"marketCap":188208998},{"date":"2024-02-02","current":-3.695148,"twenty":-7.269758,"median":-5.063995,"eighty":-2.553047,"marketCap":180101533},{"date":"2024-02-09","current":-3.588215,"twenty":-7.205245,"median":-4.989418,"eighty":-2.562386,"marketCap":174889592},{"date":"2024-02-16","current":-3.718911,"twenty":-7.15702,"median":-4.86761,"eighty":-2.569752,"marketCap":181259742},{"date":"2024-02-23","current":-3.968423,"twenty":-7.141115,"median":-4.782644,"eighty":-2.574787,"marketCap":193420939},{"date":"2024-03-01","current":-5.120929,"twenty":-7.126978,"median":-4.809209,"eighty":-2.579729,"marketCap":249594086},{"date":"2024-03-08","current":-5.192218,"twenty":-7.114429,"median":-4.86761,"eighty":-2.579915,"marketCap":253068714},{"date":"2024-03-15","current":-4.859536,"twenty":-7.101574,"median":-4.916346,"eighty":-2.583683,"marketCap":236853785},{"date":"2024-03-22","current":-5.144692,"twenty":-7.095444,"median":-4.930825,"eighty":-2.589158,"marketCap":250752296},{"date":"2024-03-28","current":-4.703502,"twenty":-7.089836,"median":-4.895181,"eighty":-2.591477,"marketCap":246327089},{"date":"2024-04-05","current":-4.405231,"twenty":-7.085449,"median":-4.848419,"eighty":-2.599721,"marketCap":230706347},{"date":"2024-04-12","current":-4.462591,"twenty":-7.075967,"median":-4.782644,"eighty":-2.603221,"marketCap":233710336},{"date":"2024-04-19","current":-3.625138,"twenty":-7.052176,"median":-4.776365,"eighty":-2.611522,"marketCap":189852098},{"date":"2024-04-26","current":-3.659554,"twenty":-7.051055,"median":-4.746204,"eighty":-2.620676,"marketCap":191654491},{"date":"2024-05-03","current":-3.99224,"twenty":-7.046226,"median":-4.732967,"eighty":-2.645525,"marketCap":209077627},{"date":"2024-05-10","current":-4.095488,"twenty":-7.042536,"median":-4.709765,"eighty":-2.655033,"marketCap":214484807},{"date":"2024-05-17","current":-4.006249,"twenty":-7.031951,"median":-4.692829,"eighty":-2.658717,"marketCap":224097571},{"date":"2024-05-24","current":-3.651809,"twenty":-7.023828,"median":-4.668715,"eighty":-2.660212,"marketCap":204271245},{"date":"2024-05-31","current":-3.200703,"twenty":-7.013201,"median":-4.655071,"eighty":-2.662946,"marketCap":179037738},{"date":"2024-06-07","current":-2.674413,"twenty":-6.98883,"median":-4.622094,"eighty":-2.673339,"marketCap":149598647},{"date":"2024-06-14","current":-2.835522,"twenty":-6.957296,"median":-4.609791,"eighty":-2.674198,"marketCap":158610613},{"date":"2024-06-21","current":-2.373676,"twenty":-6.949257,"median":-4.600351,"eighty":-2.669182,"marketCap":132776309},{"date":"2024-06-28","current":-2.534785,"twenty":-6.949154,"median":-4.599198,"eighty":-2.662946,"marketCap":141788276},{"date":"2024-07-05","current":-2.545526,"twenty":-6.899852,"median":-4.564008,"eighty":-2.652004,"marketCap":142389073},{"date":"2024-07-12","current":-2.814041,"twenty":-6.88559,"median":-4.51846,"eighty":-2.608794,"marketCap":157409018},{"date":"2024-07-15","current":-3.028853,"twenty":-6.885106,"median":-4.51846,"eighty":-2.610652,"marketCap":169424973},{"date":"2024-08-02","current":-3.469219,"twenty":-6.884691,"median":-4.51846,"eighty":-2.611522,"marketCap":194057682},{"date":"2024-08-09","current":-2.942928,"twenty":-6.879299,"median":-4.495685,"eighty":-2.620676,"marketCap":164618591},{"date":"2024-08-16","current":-2.385074,"twenty":-6.863694,"median":-4.477268,"eighty":-2.603221,"marketCap":154705428},{"date":"2024-08-23","current":-2.602741,"twenty":-6.860444,"median":-4.459078,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-08-30","current":-2.602741,"twenty":-6.848113,"median":-4.436471,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-09-06","current":-2.10257,"twenty":-6.808005,"median":-4.418252,"eighty":-2.589519,"marketCap":136381096},{"date":"2024-09-13","current":-2.269294,"twenty":-6.789035,"median":-4.418252,"eighty":-2.579729,"marketCap":147195456},{"date":"2024-09-20","current":-2.389705,"twenty":-6.77836,"median":-4.405231,"eighty":-2.565691,"marketCap":155005827},{"date":"2024-09-27","current":-2.250769,"twenty":-6.772661,"median":-4.391706,"eighty":-2.545526,"marketCap":145993860},{"date":"2024-10-04","current":-2.213719,"twenty":-6.763825,"median":-4.381813,"eighty":-2.537904,"marketCap":143590669},{"date":"2024-10-11","current":-2.084045,"twenty":-6.75499,"median":-4.351551,"eighty":-2.52363,"marketCap":135179500},{"date":"2024-10-18","current":-2.463804,"twenty":-6.75036,"median":-4.324868,"eighty":-2.493172,"marketCap":159812209},{"date":"2024-10-25","current":-2.537904,"twenty":-6.746336,"median":-4.303834,"eighty":-2.493172,"marketCap":164618591},{"date":"2024-10-31","current":-2.806514,"twenty":-6.74619,"median":-4.290341,"eighty":-2.499318,"marketCap":182041727},{"date":"2024-11-08","current":-2.936188,"twenty":-6.746154,"median":-4.256095,"eighty":-2.501671,"marketCap":190452896},{"date":"2024-11-15","current":-1.919975,"twenty":-6.744338,"median":-4.235757,"eighty":-2.492861,"marketCap":156808220},{"date":"2024-11-22","current":-1.699288,"twenty":-6.743884,"median":-4.184437,"eighty":-2.487273,"marketCap":138784287},{"date":"2024-11-29","current":-1.669864,"twenty":-6.738951,"median":-4.141738,"eighty":-2.476886,"marketCap":136381096},{"date":"2024-12-06","current":-1.55952,"twenty":-6.732888,"median":-4.12513,"eighty":-2.463368,"marketCap":127369129},{"date":"2024-12-13","current":-1.522739,"twenty":-6.729504,"median":-4.092174,"eighty":-2.444359,"marketCap":124365140},{"date":"2024-12-20","current":-1.324121,"twenty":-6.714601,"median":-4.072455,"eighty":-2.437306,"marketCap":108143600},{"date":"2024-12-27","current":-1.390327,"twenty":-6.700464,"median":-4.039868,"eighty":-2.401761,"marketCap":113550780},{"date":"2025-01-03","current":-1.360902,"twenty":-6.686699,"median":-4.021508,"eighty":-2.390383,"marketCap":111147589},{"date":"2025-01-10","current":-1.250559,"twenty":-6.66094,"median":-4.007046,"eighty":-2.380443,"marketCap":102135622},{"date":"2025-01-17","current":-1.184353,"twenty":-6.644542,"median":-4.002969,"eighty":-2.373676,"marketCap":96728442},{"date":"2025-01-24","current":-1.272627,"twenty":-6.614962,"median":-3.980769,"eighty":-2.352041,"marketCap":103938015},{"date":"2025-01-31","current":-1.147571,"twenty":-6.580597,"median":-3.965855,"eighty":-2.338607,"marketCap":93724453},{"date":"2025-02-07","current":-1.081365,"twenty":-6.566786,"median":-3.94466,"eighty":-2.323016,"marketCap":88317273},{"date":"2025-02-14","current":-1.074009,"twenty":-6.564899,"median":-3.918151,"eighty":-2.312943,"marketCap":87716475},{"date":"2025-02-21","current":-1.015159,"twenty":-6.562308,"median":-3.912497,"eighty":-2.301318,"marketCap":82910093},{"date":"2025-02-28","current":-0.926885,"twenty":-6.560601,"median":-3.900465,"eighty":-2.293717,"marketCap":75700520},{"date":"2025-03-07","current":-0.912172,"twenty":-6.556757,"median":-3.891331,"eighty":-2.270478,"marketCap":74498924},{"date":"2025-03-14","current":-0.89746,"twenty":-6.544785,"median":-3.876972,"eighty":-2.264162,"marketCap":73297329},{"date":"2025-03-21","current":-0.868035,"twenty":-6.535112,"median":-3.858033,"eighty":-2.256474,"marketCap":70894138},{"date":"2025-03-28","current":-0.728096,"twenty":-6.530944,"median":-3.854577,"eighty":-2.230367,"marketCap":74505312},{"date":"2025-04-04","current":-0.584844,"twenty":-6.525172,"median":-3.844144,"eighty":-2.213719,"marketCap":59846543},{"date":"2025-04-11","current":-0.603787,"twenty":-6.521372,"median":-3.829108,"eighty":-2.194295,"marketCap":61784893},{"date":"2025-04-17","current":-0.580109,"twenty":-6.515538,"median":-3.829108,"eighty":-2.181634,"marketCap":59361956},{"date":"2025-04-25","current":-0.651143,"twenty":-6.502285,"median":-3.796141,"eighty":-2.168921,"marketCap":66630767},{"date":"2025-05-02","current":-0.633384,"twenty":-6.492658,"median":-3.771671,"eighty":-2.161623,"marketCap":64813564},{"date":"2025-05-09","current":-0.591948,"twenty":-6.483739,"median":-3.736733,"eighty":-2.105653,"marketCap":60573425},{"date":"2025-05-16","current":-0.526263,"twenty":-6.462771,"median":-3.718911,"eighty":-2.026703,"marketCap":61179159},{"date":"2025-05-23","current":-0.536684,"twenty":-6.443969,"median":-3.695118,"eighty":-1.923456,"marketCap":62390627},{"date":"2025-05-30","current":-0.547105,"twenty":-6.440173,"median":-3.689743,"eighty":-1.875701,"marketCap":63602096},{"date":"2025-06-06","current":-0.557526,"twenty":-6.43497,"median":-3.671385,"eighty":-1.8063,"marketCap":64813564},{"date":"2025-06-13","current":-0.594,"twenty":-6.426936,"median":-3.659529,"eighty":-1.76974,"marketCap":69053704},{"date":"2025-06-20","current":-0.635684,"twenty":-6.40475,"median":-3.658151,"eighty":-1.757349,"marketCap":73899578},{"date":"2025-06-27","current":-0.630474,"twenty":-6.383401,"median":-3.651809,"eighty":-1.742663,"marketCap":73293844},{"date":"2025-07-03","current":-0.604421,"twenty":-6.374855,"median":-3.648082,"eighty":-1.728566,"marketCap":70265173},{"date":"2025-07-11","current":-0.677369,"twenty":-6.371048,"median":-3.630874,"eighty":-1.703143,"marketCap":78745452},{"date":"2025-07-18","current":-0.771158,"twenty":-6.367097,"median":-3.618507,"eighty":-1.692733,"marketCap":89648669},{"date":"2025-07-25","current":-0.838895,"twenty":-6.362679,"median":-3.608934,"eighty":-1.669864,"marketCap":97523214},{"date":"2025-08-01","current":-0.729474,"twenty":-6.358261,"median":-3.598348,"eighty":-1.652677,"marketCap":84802795},{"date":"2025-08-08","current":-0.739895,"twenty":-6.353843,"median":-3.584215,"eighty":-1.644081,"marketCap":86014263},{"date":"2025-08-15","current":-0.620516,"twenty":-6.351694,"median":-3.541925,"eighty":-1.621417,"marketCap":84802795},{"date":"2025-08-22","current":-0.602787,"twenty":-6.348535,"median":-3.530944,"eighty":-1.613202,"marketCap":82379858}],"updateTime":1756095056764},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABOS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562701245","title":"Acumen price target lowered to $9 from $10 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2562701245","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562701245?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:10","pubTimestamp":1756120241,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Acumen (ABOS) to $9 from $10 and keeps a Buy rating on the shares, citing the updated cash position followi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acumen-price-target-lowered-to-9-from-10-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acumen-price-target-lowered-to-9-from-10-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2559971229","title":"BTIG Keeps Their Buy Rating on Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2559971229","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559971229?lang=en_us&edition=fundamental","pubTime":"2025-08-15 15:25","pubTimestamp":1755242710,"startTime":"0","endTime":"0","summary":"BTIG analyst Thomas Shrader reiterated a Buy rating on Acumen Pharmaceuticals yesterday and set a price target of $11.00. The company’s shares clos...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-acumen-pharmaceuticals-abos-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-acumen-pharmaceuticals-abos-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABOS"],"gpt_icon":0},{"id":"2559673941","title":"Citi Sticks to Their Buy Rating for Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2559673941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559673941?lang=en_us&edition=fundamental","pubTime":"2025-08-13 09:35","pubTimestamp":1755048931,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Acumen Pharmaceuticals on August 11 and set a price target of $4.00. The company’s shares clo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-their-buy-rating-for-acumen-pharmaceuticals-abos-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-their-buy-rating-for-acumen-pharmaceuticals-abos-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABOS"],"gpt_icon":0},{"id":"2558474606","title":"Acumen Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2558474606","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558474606?lang=en_us&edition=fundamental","pubTime":"2025-08-12 21:31","pubTimestamp":1755005469,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryAcumen Pharmaceuticals Inc ABOS.OQ reported a quarterly adjusted loss of 68 cents per share for the quarter e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL8N3U412P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2558649742","title":"Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -41.75 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649742","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649742?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:14","pubTimestamp":1754997294,"startTime":"0","endTime":"0","summary":"Aug 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q2 operating expenses USD 41.75 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 12-AUG-202510:45:00.177 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nRSD4qX1ws:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2558264966","title":"Acumen Pharmaceuticals Q2 EPS $(0.68) Misses $(0.52) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2558264966","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558264966?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996457,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.52) by 31.53 percent. This is a 100 percent decrease over losses of $(0.34) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47054420/acumen-pharmaceuticals-q2-eps-0-68-misses-0-52-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2558649679","title":"Acumen Pharmaceuticals Inc - Topline Results for Altitude-Ad Phase 2 Expected Late 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649679?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nPLX071404:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2558649396","title":"Acumen Pharmaceuticals, Inc. Q2 Operating Expenses USD 41.75 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649396","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649396?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nPLX071404:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2558381649","title":"Acumen Pharmaceuticals, Inc. Q2 Net Income USD -40.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2558381649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558381649?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nPLX071404:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2557575800","title":"Acumen Pharmaceuticals Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557575800","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557575800?lang=en_us&edition=fundamental","pubTime":"2025-08-08 23:32","pubTimestamp":1754667125,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc  expected to post a loss of52cents a share - Earnings Preview Acumen Pharmaceuticals Inc ABOS.OQ ABOS.O is expected to  show no change in quarterly revenue when it reports  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U02RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2557319922","title":"Acumen Pharmaceuticals Inc. to Report Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557319922","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557319922?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:00","pubTimestamp":1754424008,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc. will report its second quarter 2025 financial results on August 12, 2025. The results will be released on the company's website. A conference call and live audio webcast will be hosted at 8:00 a.m. ET to provide a business and financial update. The webcast audio will be available via thislink.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acumen Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on August 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL8lSMgV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4585","IE00BKPKM429.USD","BK4588","BK4112","LU2095319765.USD","BK4139","NDAQ","ABOS","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4539"],"gpt_icon":0},{"id":"2557319730","title":"Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2557319730","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557319730?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:00","pubTimestamp":1754424000,"startTime":"0","endTime":"0","summary":"NEWTON, Mass., Aug.  05, 2025  (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/05/3127781/0/en/Acumen-Pharmaceuticals-to-Report-Second-Quarter-2025-Financial-Results-on-August-12-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2556481031","title":"Acumen Pharmaceuticals’ Promising Alzheimer’s Study: A Potential Game-Changer?","url":"https://stock-news.laohu8.com/highlight/detail?id=2556481031","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556481031?lang=en_us&edition=fundamental","pubTime":"2025-08-02 00:16","pubTimestamp":1754064993,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals, Inc. (($ABOS)) announced an update on their ongoing clinical study. Acumen Pharmaceuticals, Inc. is conducting a Phase 2 cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acumen-pharmaceuticals-promising-alzheimers-study-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acumen-pharmaceuticals-promising-alzheimers-study-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2554527779","title":"Acumen Pharmaceuticals Announces 40% Cost Reduction in Phase 2 Alzheimer's Trial with Innovative pTau217 Screening Assay","url":"https://stock-news.laohu8.com/highlight/detail?id=2554527779","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554527779?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:00","pubTimestamp":1753704029,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals, Inc.  has announced the results of a study demonstrating the effectiveness of a pTau217 screening assay in reducing clinical trial screening costs by approximately 40% in its Phase 2 ALTITUDE-AD study of sabirnetug for early Alzheimer's disease in the U.S. and Canada. The study also highlighted sabirnetug's high selectivity for amyloid beta oligomers over monomers compared to recombinant lecanemab and aducanumab. These findings were presented at the Alzheimer's Association International Conference  2025, held in Toronto and online. The innovative two-step screening process using a plasma pTau217 biomarker assay contributed to significant cost efficiencies and helped achieve strong enrollment rates by reducing unnecessary procedures.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDL3K0cHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4588","LU2210149790.SGD","LU2210150020.SGD","BK4139","IE00B3QW5Z07.USD","NDAQ","IE00B64PRP62.GBP","LU2095319765.USD","BK4539","ABOS","BK4585","BK4112","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2554779490","title":"Acumen Pharmaceuticals Presents Studies Showing the Utility of a Ptau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (Aaic) 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2554779490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554779490?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:00","pubTimestamp":1753704000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nTUA1SFGWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2551719164","title":"Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2551719164","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551719164?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:59","pubTimestamp":1752580787,"startTime":"0","endTime":"0","summary":"An announcement from Acumen Pharmaceuticals ( ($ABOS) ) is now available. On July 15, 2025, Acumen Pharmaceuticals announced a strategic collaborat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acumen-pharmaceuticals-partners-with-jcr-for-alzheimers-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acumen-pharmaceuticals-partners-with-jcr-for-alzheimers-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2551460161","title":"Acumen, JCR enter agreement to develop therapeutic candidate for Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2551460161","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551460161?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:21","pubTimestamp":1752578489,"startTime":"0","endTime":"0","summary":"JCR Pharmaceutical announced a joint collaboration, option and license agreement with Acumen (ABOS) to develop a novel therapeutic candidate for th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acumen-jcr-enter-agreement-to-develop-therapeutic-candidate-for-alzheimers-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acumen-jcr-enter-agreement-to-develop-therapeutic-candidate-for-alzheimers-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2551690741","title":"Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2551690741","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551690741?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:00","pubTimestamp":1752577200,"startTime":"0","endTime":"0","summary":"Acumen and JCR aim to develop a product leveraging Acumen’s amyloid beta oligomer-selective antibody expertise and JCR’s transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/15/3115461/0/en/Acumen-Pharmaceuticals-and-JCR-Pharmaceuticals-Enter-Strategic-Collaboration-Option-and-License-Agreement-to-Develop-Enhanced-Brain-Delivery-Therapy-for-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4539","CNS","ABOS","BK4139"],"gpt_icon":0},{"id":"2550474596","title":"Acumen Pharmaceuticals Unveils New Cost-Saving Screening Assay in Phase 2 Alzheimer's Study at 2025 AAIC Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2550474596","media":"Reuters","labels":["productRelease","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550474596?lang=en_us&edition=fundamental","pubTime":"2025-07-10 20:00","pubTimestamp":1752148831,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is set to present new findings at the Alzheimer's Association International Conference  2025 in Toronto. The presentations will include a cost savings analysis of the use of pTau217 as a screening tool in the company's Phase 2 ALTITUDE-AD trial of the therapeutic agent sabirnetug, as well as a nonclinical study on sabirnetug's selectivity for targeting amyloid beta oligomers  compared to amyloid beta monomers. These results will be shared during poster presentations scheduled for July 28 and July 29, 2025, respectively. The studies emphasize sabirnetug's potential efficacy in treating early Alzheimer's disease and its distinct selectivity for toxic AβOs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL4khxkk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4539","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4588","BK4585","LU2095319765.USD","LU2210150020.SGD","ABOS","NDAQ","BK4112","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139"],"gpt_icon":0},{"id":"2544964524","title":"Acumen Pharmaceuticals Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544964524?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:45","pubTimestamp":1750160700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 17, 2025 07:45 ET (11:45 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}